T4K3.news
NHS urged to support patients after obesity treatment
Experts call for long-term support for patients ceasing weight-loss medications.
NHS is urged to provide sustained support for patients after obesity treatment.
Support essential for patients stopping obesity medications
In England, obesity impacts approximately one in four adults, with about 1.5 million individuals on weight loss medications like Wegovy and Mounjaro. While Wegovy is available on NHS prescriptions for those with serious weight-related health issues, many patients pay privately for their medications and thus lack NHS support after they stop treatment. Data shows that patients can regain about two-thirds of their weight once they cease these injections, prompting experts from NICE to recommend long-term behavioral support. They emphasize the necessity for patients to maintain progress after treatment. Experts believe that individualized strategies, along with preventive measures, are crucial in managing obesity effectively.
Key Takeaways
"Successful weight management doesn't end when medication stops or when someone completes a behavioural programme."
This emphasizes the ongoing support needed for patients after treatment.
"What works for one patient will likely not work for another."
This underscores the necessity of personalized treatment strategies in obesity care.
The issue of obesity management is coming to the forefront as medication like Wegovy and Mounjaro gains traction. With many patients regaining weight after discontinuation, there is a growing call for the NHS to implement dedicated support systems. The insights from health professionals suggest the need for tailored strategies that cater to individual patient experiences. This highlights the broader challenge of tackling obesity not just through medication, but with comprehensive lifestyle changes and support structures.
Highlights
- Losing weight is just the beginning; keeping it off requires ongoing support.
- Support is vital after weight-loss medication, not just during treatment.
- A tailored approach might be the key to successful weight management.
- We need to rethink obesity treatment, focusing on prevention and support.
Need for continued support raises concerns
Many patients who rely on private prescriptions for obesity medications may lack crucial support after treatment ends, leading to weight regain and potential health issues.
As obesity continues to challenge public health, a focus on comprehensive support may yield better outcomes.
Enjoyed this? Let your friends know!
Related News
Weight loss injections gain popularity in treatment
Warning on counterfeit weight loss jabs
New guidelines issued for weight loss drug patients
Mounjaro shows promise in reducing alcohol cravings
SSRIs safety signals prompt review
Growing panic among Mounjaro users due to shortages
Ambulance costs rise for bariatric transport
Heart failure risk linked to pregabalin study
